Dr John William Johnson, MD | |
2907 E Joyce Blvd, Fayetteville, AR 72703-5011 | |
(479) 521-8260 | |
Not Available |
Full Name | Dr John William Johnson |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 2907 E Joyce Blvd, Fayetteville, Arkansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730354333 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | E-6033 (Arkansas) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Entity Name | South Arkansas Emergency Physicians Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942435458 PECOS PAC ID: 4486705720 Enrollment ID: O20090629000005 |
News Archive
On June 13, CreakyJoints, a Global Healthy Living Foundation patient community, will present a poster at the Annual European Congress of Rheumatology meeting in Madrid, Spain. Two additional abstracts were accepted for publication.
Today's headlines include reports about Kevin Counihan, the person who take on the challenge of running healthcare.gov.
A team of scientists at Tufts University will develop ultra-sensitive techniques at the single-molecule and single-cell levels designed to detect breast cancer earlier, and treat it with greater precision, through a $6.6 million Innovator Award from the Department of Defense Breast Cancer Research Program made to Tufts chemist David R. Walt, Ph.D.
Stand Up To Cancer has awarded a $2.5 million SU2C CatalystR grant to the Translational Genomics Research Institute to investigate a revolutionary new method of treating pancreatic cancer, one of the most aggressive of all cancers.
› Verified 4 days ago
Entity Name | White River Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578872297 PECOS PAC ID: 0143134270 Enrollment ID: O20110111000718 |
News Archive
On June 13, CreakyJoints, a Global Healthy Living Foundation patient community, will present a poster at the Annual European Congress of Rheumatology meeting in Madrid, Spain. Two additional abstracts were accepted for publication.
Today's headlines include reports about Kevin Counihan, the person who take on the challenge of running healthcare.gov.
A team of scientists at Tufts University will develop ultra-sensitive techniques at the single-molecule and single-cell levels designed to detect breast cancer earlier, and treat it with greater precision, through a $6.6 million Innovator Award from the Department of Defense Breast Cancer Research Program made to Tufts chemist David R. Walt, Ph.D.
Stand Up To Cancer has awarded a $2.5 million SU2C CatalystR grant to the Translational Genomics Research Institute to investigate a revolutionary new method of treating pancreatic cancer, one of the most aggressive of all cancers.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr John William Johnson, MD 21952 Richland View Rd, Elkins, AR 72727-8641 Ph: (870) 275-0320 | Dr John William Johnson, MD 2907 E Joyce Blvd, Fayetteville, AR 72703-5011 Ph: (479) 521-8260 |
News Archive
On June 13, CreakyJoints, a Global Healthy Living Foundation patient community, will present a poster at the Annual European Congress of Rheumatology meeting in Madrid, Spain. Two additional abstracts were accepted for publication.
Today's headlines include reports about Kevin Counihan, the person who take on the challenge of running healthcare.gov.
A team of scientists at Tufts University will develop ultra-sensitive techniques at the single-molecule and single-cell levels designed to detect breast cancer earlier, and treat it with greater precision, through a $6.6 million Innovator Award from the Department of Defense Breast Cancer Research Program made to Tufts chemist David R. Walt, Ph.D.
Stand Up To Cancer has awarded a $2.5 million SU2C CatalystR grant to the Translational Genomics Research Institute to investigate a revolutionary new method of treating pancreatic cancer, one of the most aggressive of all cancers.
› Verified 4 days ago